Does COVID-19 impact the QT interval prolongation? Answers from genetic causal inference. [PDF]
Song Y, Zheng Z.
europepmc +1 more source
Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection. [PDF]
Zhao W +5 more
europepmc +1 more source
Cardiovascular Safety of VIAN‐c4551, an Antiangiogenic Peptide Derived From Vasoinhibin
ABSTRACT Vasoinhibin is a potent antiangiogenic protein that blocks the activation of endothelial nitric oxide synthase (eNOS) in response to vascular endothelial growth factor, bradykinin, and acetylcholine (ACh). In this regard, VIAN‐c4551, a new synthetic vasoinhibin analog, has therapeutic potential for targeting angiogenesis in oncology and ...
Miguel A. García‐González +13 more
wiley +1 more source
Impact of hypokalemia on Brugada syndrome: case report unveiling mechanisms beyond QT interval prolongation. [PDF]
Siregar MNI, Wahidji VH.
europepmc +1 more source
Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor. [PDF]
Nakayama Y +6 more
europepmc +1 more source
392 A Prospective Study Evaluating QT Intervals After Antiemetics and Antihistamines in Unfunded Emergent Dialysis With Baseline QT Prolongation [PDF]
Lynn P. Roppolo +6 more
openalex +1 more source
ABSTRACT Background Patients with beta‐thalassemia major are prone for developing cardiovascular complications. Early identification of patients at risk is important. B‐type natriuretic peptides such as brain natriuretic peptide (BNP) and N‐terminal pro‐BNP (NT‐proBNP) are sensitive indicators of cardiac dysfunction.
Mohamed S. K. Salih +9 more
wiley +1 more source
Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation. [PDF]
Lazzerini PE +19 more
europepmc +1 more source
Abstract Fruquintinib is a highly selective oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, approved by the US Food and Drug Administration and the European Commission for the treatment of previously treated metastatic colorectal cancer (mCRC), regardless of biomarker status. This study used concentration QT interval (C‐QTc)
Xiaofei Zhou +7 more
wiley +1 more source

